Ozempic Lawsuits: Who Qualifies and What Settlement Talks Mean
Overview of Ozempic litigation criteria, current case status and what settlement negotiations mean for claimants. Plain facts on eligibility and timelines.
Ozempic Lawsuits: Criteria, Status and Settlement Talk
Multiple lawsuits against the makers of Ozempic involve claims of serious side effects not adequately disclosed to users. Here's what you need to know about eligibility, case status and the settlement process.
Who Qualifies
Lawsuit criteria typically require:
- Use of Ozempic or similar GLP-1 medications (Mounjaro, Wegovy, others)
- Development of a serious adverse event, commonly thyroid cancer, pancreatitis or gastroparesis
- Medical records documenting the condition and its timeline
- Use of the medication before diagnosis
Not all users qualify. The specific condition matters, as do dates of use and diagnosis.
Current Case Status
Multiple cases proceed through federal and state courts. Early phases include motion hearings and discovery. Settlement discussions are happening, but no widespread agreement has been reached across all cases.
What Settlement Talks Actually Mean
Settlement negotiation is an early-stage process where lawyers exchange information about case strength, damages and risk. It does not mean money is coming soon or that cases are resolved.
Settlements typically involve confidentiality agreements. You may not be able to discuss terms publicly.
Next Steps
If you believe you qualify, consult a lawyer experienced in product liability. Time limits on filing vary by state and injury type.